...
首页> 外文期刊>Cancer research: The official organ of the American Association for Cancer Research, Inc >Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
【24h】

Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.

机译:肿瘤抑制因子DKC1的功能丧失会干扰p27的翻译控制,并有助于垂体肿瘤的发生。

获取原文
获取原文并翻译 | 示例
           

摘要

Mutations in DKC1, encoding for dyskerin, a pseudouridine synthase that modifies rRNA and regulates telomerase activity, are associated with ribosomal dysfunction and increased cancer susceptibility in the human syndrome, X-linked dyskeratosis congenita (X-DC). In a mouse model for X-DC, impairments in DKC1 function affected the translation of specific mRNAs harboring internal ribosomal entry site (IRES) elements, including the tumor suppressor, p27. However, how this translational deregulation contributes to tumor initiation and progression remains poorly understood. Here, we report that impairment in p27 IRES-mediated translation due to decreased levels of DKC1 activity markedly increases spontaneous pituitary tumorigenesis in p27 heterozygous mice. Using a new bioluminescent mouse model, we monitored p27 translation in vivo and show that p27 IRES-mediated translation is reduced in the pituitary of DKC1 hypomorphic mice (DKC1(m)). Furthermore, we show that DKC1 has a critical role in regulating the assembly of the 48S translational preinitiation complex mediated by the p27 IRES element. An analysis of human tumors identified a novel mutation of DKC1 (DKC1(S485G)) in a human pituitary adenoma. We show that this specific amino acid substitution significantly alters DKC1 stability/pseudouridylation activity, and this correlates with reductions in p27 protein levels. Furthermore, DKC1(S485G) mutation does not alter telomerase RNA levels. Altogether, these findings show that genetic alterations in DKC1 could contribute to tumorigenesis associated with somatic cancers and establish a critical role for DKC1 in tumor suppression, at least in part, through translational control of p27.
机译:DKC1中的突变编码为dyskerin(一种伪尿苷合酶,可修饰rRNA并调节端粒酶活性),与核糖体功能障碍和人类综合症X连锁性先天性角化病(X-DC)的易感性增加相关。在X-DC的小鼠模型中,DKC1功能的受损影响了具有内部核糖体进入位点(IRES)元件的特定mRNA的翻译,包括肿瘤抑制因子p27。然而,这种翻译失调如何促进肿瘤的发生和发展仍知之甚少。在这里,我们报告说,由于DKC1活性水平降低,在p27 IRES介导的翻译中的损伤显着增加了p27杂合小鼠的自发性垂体肿瘤发生。使用新的生物发光小鼠模型,我们在体内监测了p27翻译,并显示DKC1亚型小鼠(DKC1(m))的垂体中p27 IRES介导的翻译减少。此外,我们表明DKC1在调节由p27 IRES元件介导的48S翻译预启复合物的装配中具有关键作用。对人类肿瘤的分析确定了人类垂体腺瘤中DKC1(DKC1(S485G))的新型突变。我们表明,这种特定的氨基酸取代显着改变DKC1稳定性/伪尿苷化活性,并且这与p27蛋白水平的降低有关。此外,DKC1(S485G)突变不会改变端粒酶RNA水平。总而言之,这些发现表明,DKC1的遗传改变可能有助于与体细胞癌相关的肿瘤发生,并至少部分地通过对p27的翻译控制在DKC1抑制肿瘤中发挥关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号